SE7612963L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7612963L
SE7612963L SE7612963A SE7612963A SE7612963L SE 7612963 L SE7612963 L SE 7612963L SE 7612963 A SE7612963 A SE 7612963A SE 7612963 A SE7612963 A SE 7612963A SE 7612963 L SE7612963 L SE 7612963L
Authority
SE
Sweden
Prior art keywords
pharmaceutically acceptable
acceptable salts
gram
novel
tienamycin
Prior art date
Application number
SE7612963A
Other languages
English (en)
Other versions
SE427841B (sv
Inventor
B G Christensen
W J Leanza
K J Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612963L publication Critical patent/SE7612963L/sv
Publication of SE427841B publication Critical patent/SE427841B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7612963A 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat SE427841B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US67626176A 1976-04-12 1976-04-12
US73365476A 1976-10-18 1976-10-18

Publications (2)

Publication Number Publication Date
SE7612963L true SE7612963L (sv) 1977-05-22
SE427841B SE427841B (sv) 1983-05-09

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612963A SE427841B (sv) 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat

Country Status (27)

Country Link
AT (1) AT358168B (sv)
AU (1) AU512383B2 (sv)
BG (1) BG34037A3 (sv)
CA (1) CA1083577A (sv)
CH (2) CH632510A5 (sv)
DD (1) DD127742A5 (sv)
DE (1) DE2652679A1 (sv)
DK (1) DK157401C (sv)
EG (1) EG12261A (sv)
ES (1) ES453501A1 (sv)
FI (1) FI62306C (sv)
FR (1) FR2332012A1 (sv)
GB (1) GB1570990A (sv)
GR (1) GR62072B (sv)
HK (1) HK29683A (sv)
HU (1) HU180865B (sv)
IE (1) IE44433B1 (sv)
IL (1) IL50911A (sv)
KE (1) KE3286A (sv)
NL (1) NL189297C (sv)
NO (1) NO153298C (sv)
NZ (1) NZ182630A (sv)
PH (1) PH16714A (sv)
PL (1) PL110937B1 (sv)
PT (1) PT65865B (sv)
SE (1) SE427841B (sv)
SG (1) SG10983G (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK170778A (da) * 1977-05-05 1979-01-15 Merck & Co Inc Fremgangsmaade til fremstilling af n-alkyl-n-iminomethyl-derivater af thienamycin
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
DK157401C (da) 1990-05-21
PL110937B1 (en) 1980-08-30
FI62306C (fi) 1982-12-10
FR2332012A1 (fr) 1977-06-17
PL193809A1 (pl) 1978-01-16
ATA863476A (de) 1980-01-15
NL7612939A (nl) 1977-05-24
PT65865B (en) 1978-10-12
SG10983G (en) 1983-12-16
NO153298C (no) 1986-02-19
AU1964776A (en) 1978-05-25
BG34037A3 (en) 1983-06-15
IE44433B1 (en) 1981-12-02
DK523576A (da) 1977-05-22
PT65865A (en) 1976-12-01
DE2652679C2 (sv) 1990-03-01
GR62072B (en) 1979-02-20
KE3286A (en) 1983-06-17
FR2332012B1 (sv) 1978-11-17
FI763308A (sv) 1977-05-22
ES453501A1 (es) 1978-03-01
SE427841B (sv) 1983-05-09
DD127742A5 (de) 1977-10-12
NZ182630A (en) 1979-07-11
FI62306B (fi) 1982-08-31
IL50911A (en) 1981-01-30
AT358168B (de) 1980-08-25
AU512383B2 (en) 1980-10-09
CH633800A5 (en) 1982-12-31
NL189297B (nl) 1992-10-01
NO153298B (no) 1985-11-11
CH632510A5 (en) 1982-10-15
HK29683A (en) 1983-08-26
NL189297C (nl) 1993-03-01
EG12261A (en) 1978-12-31
NO763958L (sv) 1977-05-24
PH16714A (en) 1984-01-25
DK157401B (da) 1990-01-02
CA1083577A (en) 1980-08-12
IE44433L (en) 1977-05-21
IL50911A0 (en) 1977-01-31
DE2652679A1 (de) 1977-06-02
GB1570990A (en) 1980-07-09
HU180865B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
ES8500242A1 (es) Procedimiento para la preparacion de derivados de imidazol
NO834146L (no) Fremgangsmaate for fremstilling av epimert azahomoerytromycin a
AU555444B2 (en) Cephalosporin derivatives
SE7612963L (sv) Tienamycinderivat
SE7612962L (sv) Tienamycinderivat
ES2125945T3 (es) Derivados antimicrobianos del carbapenemo, su preparacion y su utilizacion terapeutica.
FR2361114A1 (fr) Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus
SE7612295L (sv) Antibiotikum
ZA792571B (en) Cephem derivatives and process for their manufacture
SE7612961L (sv) Tienamycinderivat
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
SE7702370L (sv) Tienamycinderivat
SE7612960L (sv) Tienamycinderivat
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
ES430676A1 (es) Procedimiento para la preparacion de 1,2,4-tiadiazolo- (2,3-a) bencimidazoles-2-sustituidos.
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
GB1533413A (en) Penicillins
SE8404556L (sv) Farmaceutisk komposition
FI864537A0 (fi) Kefalosporinderivat och foerfarande foer deras framstaellning.
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
IL48358A (en) 1-(5-alkyl-1,3,4-thiadiazol-2-yl)-5-(alkanoyloxy)-3-alkyl-2-imidazolidinones
SE7708053L (sv) Nya antibakteriella cefalosporinsyror

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7612963-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7612963-4

Format of ref document f/p: F